Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -274,477 | -112,961 | -58,655 | -49,762 | -34,495 |
| Depreciation Amortization | -19,399 | -7,545 | 2,820 | 3,559 | 1,959 |
| Accounts receivable | 15 | 193 | 892 | 774 | -1,877 |
| Accounts payable and accrued liabilities | 8,280 | 2,635 | 1,864 | 1,166 | 225 |
| Other Working Capital | 11,546 | -13,207 | -42,969 | -17,813 | 84,406 |
| Other Operating Activity | 26,451 | 15,661 | 8,873 | 6,297 | 5,245 |
| Operating Cash Flow | $-247,584 | $-115,224 | $-87,175 | $-55,779 | $55,463 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -498,702 | -156,088 | -29,961 | -67,022 | -145,750 |
| PPE Investments | -3,857 | -2,368 | -3,443 | -2,644 | -493 |
| Investing Cash Flow | $-502,559 | $-158,456 | $-33,404 | $-69,666 | $-146,243 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 676,112 | 361,504 | 96,410 | 144,757 | 128,424 |
| Other Financing Activity | 1,439 | 1,213 | 755 | 697 | 326 |
| Financing Cash Flow | $677,551 | $362,717 | $97,165 | $145,454 | $128,750 |
| Beginning Cash Position | 157,775 | 68,738 | 92,152 | 72,143 | 34,173 |
| End Cash Position | 85,183 | 157,775 | 68,738 | 92,152 | 72,143 |
| Net Cash Flow | $-72,592 | $89,037 | $-23,414 | $20,009 | $37,970 |
| Free Cash Flow | |||||
| Operating Cash Flow | -247,584 | -115,224 | -87,175 | -55,779 | 55,463 |
| Capital Expenditure | -3,857 | -2,368 | -3,443 | -2,644 | -493 |
| Free Cash Flow | -251,441 | -117,592 | -90,618 | -58,423 | 54,970 |